Reference
1. Goeser MR, Laniosz V, Wetter DA. A practical approach to the diagnosis, evaluation, and management of cutaneous small-vessel vasculitis. Am J Clin Dermatol. 2014;15(4):299-306.
2. Micheletti RG, Pagnoux C. Management of cutaneous vasculitis. Presse Med. 2020;49(3):104033.
3. Fiorentino DF. Cutaneous vasculitis. J Am Acad Dermatol. 2003;48(3):311-40.
4. Fan TH, Khoury J, Cho SM, Bhimraj A, Shoskes A, Uchino K. Cerebrovascular complications and vasculopathy in patients with herpes simplex virus central nervous system infection. J Neurol Sci. 2020;419:117200.
5. Nagel MA, Bubak AN. Varicella Zoster Virus Vasculopathy. J Infect Dis. 2018;218(suppl_2):S107-S12.
6. Arslan F, Batirel A, Mert A, Ozer S. Cytomegalovirus (CMV)-related cutaneous necrotizing vasculitis: case report and literature review. Braz J Infect Dis. 2012;16(5):482-5.
7. Noonan TP, Konstantinov KN, Echevarria L. Epstein-Barr virus reactivation induced myeloperoxidase-specific antineutrophil cytoplasmic antibody (MPO-ANCA)-associated vasculitis. BMJ Case Rep. 2021;14(10).
8. Calvario A, Foti C, Scarasciulli M, Romita P, Eliassen E, Marzullo A, et al. Leukocytoclastic Vasculitis Associated with HHV6-A/ciHHV6-A and HHV6-B Coinfection in an Immunocompetent Woman. Endocr Metab Immune Disord Drug Targets. 2019;19(2):221-5.
9. Agut H, Bonnafous P, Gautheret-Dejean A. Laboratory and clinical aspects of human herpesvirus 6 infections. Clin Microbiol Rev. 2015;28(2):313-35.
10. Sekula P, Del Greco MF, Pattaro C, Kottgen A. Mendelian Randomization as an Approach to Assess Causality Using Observational Data. J Am Soc Nephrol. 2016;27(11):3253-65.
11. Davies NM, Holmes MV, Davey Smith G. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ. 2018;362:k601.
12. Burgess S, Davies NM, Thompson SG. Bias due to participant overlap in two-sample Mendelian randomization. Genet Epidemiol. 2016;40(7):597-608.
13. Pierce BL, Ahsan H, Vanderweele TJ. Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants. Int J Epidemiol. 2011;40(3):740-52.
14. Burgess S, Thompson SG. Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol. 2017;32(5):377-89.
15. Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator. Genet Epidemiol. 2016;40(4):304-14.
16. Bowden J, Spiller W, Del Greco MF, Sheehan N, Thompson J, Minelli C, et al. Improving the visualization, interpretation and analysis of two-sample summary data Mendelian randomization via the Radial plot and Radial regression. Int J Epidemiol. 2018;47(4):1264-78.
17. Zheng J, Baird D, Borges MC, Bowden J, Hemani G, Haycock P, et al. Recent Developments in Mendelian Randomization Studies. Curr Epidemiol Rep. 2017;4(4):330-45.
18. Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife. 2018;7.
19. Drago F, Rampini P, Brusati C, Rebora A. Leukocytoclastic vasculitis in a patient with HHV-6 infection. Acta Derm Venereol. 2000;80(1):68.
20. Arora A, Wetter DA, Gonzalez-Santiago TM, Davis MD, Lohse CM. Incidence of leukocytoclastic vasculitis, 1996 to 2010: a population-based study in Olmsted County, Minnesota. Mayo Clin Proc. 2014;89(11):1515-24.
21. Pastuszczak M, Celinska-Lowenhoff M, Sulowicz J, Wojas-Pelc A, Musial J. Clinical study on single-organ cutaneous small vessels vasculitis (SoCSVV). Medicine (Baltimore). 2017;96(12):e6376.
22. Pipitone N, Salvarani C. The role of infectious agents in the pathogenesis of vasculitis. Best Pract Res Clin Rheumatol. 2008;22(5):897-911.
23. Barnadas MA, Perez E, Gich I, Llobet JM, Ballarin J, Calero F, et al. Diagnostic, prognostic and pathogenic value of the direct immunofluorescence test in cutaneous leukocytoclastic vasculitis. Int J Dermatol. 2004;43(1):19-26.
24. Gambichler T, Kulik MA, Skrygan M, Rooms I, Hoxtermann S. Cutaneous leukocytoclastic vasculitis: the role of lymphocytes and related immune markers. Postepy Dermatol Alergol. 2017;34(4):299-305.
25. Abdel-Haq NM, Asmar BI. Human herpesvirus 6 (HHV6) infection. Indian J Pediatr. 2004;71(1):89-96.
26. McAdoo SP, Pusey CD. Is there a role for TNFalpha blockade in ANCA-associated vasculitis and glomerulonephritis? Nephrol Dial Transplant. 2017;32(suppl_1):i80-i8.
27. Ba H, Xu L, Peng H, Lin Y, Li X, Wang H, et al. Chronic Active Epstein-Barr Virus Infection With Systemic Vasculitis and Pulmonary Arterial Hypertension in a Child. Front Pediatr. 2019;7:219.
28. Hu HB, Wu JG, Cheng Y, Li JJ. Epidemiology and Clinical Characteristics of Henoch-Schonlein Purpura Associated with Epstein-Barr Virus Infection. Mediterr J Hematol Infect Dis. 2021;13(1):e2021064.
29. Mayer CS, Blobner K, Storr J, Baur ID, Khoramnia R. Acute Retinal Necrosis: Signs, Treatment, Complications and Outcome. Diagnostics (Basel). 2022;12(2).
30. Patil A, Goldust M, Wollina U. Herpes zoster: A Review of Clinical Manifestations and Management. Viruses. 2022;14(2).
31. Tiong BK, Singh AS, Sarantopoulos GP, Kermani TA. Kaposi sarcoma in anti-neutrophil cytoplasmic antibody-associated vasculitis: a case-based review. Rheumatol Int. 2021;41(7):1357-67.
32. Yin KJ, Huang JX, Wang P, Yang XK, Tao SS, Li HM, et al. No Genetic Causal Association Between Periodontitis and Arthritis: A Bidirectional Two-Sample Mendelian Randomization Analysis. Front Immunol. 2022;13:808832.